Syros Pharmaceuticals Statistics
Total Valuation
SYRS has a market cap or net worth of $167.59 million. The enterprise value is $118.83 million.
| Market Cap | 167.59M |
| Enterprise Value | 118.83M |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, before market open.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SYRS has 26.73 million shares outstanding. The number of shares has increased by 40.00% in one year.
| Shares Outstanding | 26.73M |
| Shares Change (YoY) | +40.00% |
| Shares Change (QoQ) | +31.88% |
| Owned by Insiders (%) | 1.44% |
| Owned by Institutions (%) | 82.77% |
| Float | 12.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 24.01 |
| Forward PS | n/a |
| PB Ratio | 11.13 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 17.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.01, with a Debt / Equity ratio of 4.10.
| Current Ratio | 3.01 |
| Quick Ratio | n/a |
| Debt / Equity | 4.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -26.70 |
Financial Efficiency
Return on equity (ROE) is -409.20% and return on invested capital (ROIC) is -165.12%.
| Return on Equity (ROE) | -409.20% |
| Return on Assets (ROA) | -91.50% |
| Return on Capital (ROIC) | -165.12% |
| Revenue Per Employee | $102,662 |
| Profits Per Employee | -$2.12M |
| Employee Count | 68 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +79.14% in the last 52 weeks. The beta is 1.53, so SYRS's price volatility has been higher than the market average.
| Beta (5Y) | 1.53 |
| 52-Week Price Change | +79.14% |
| 50-Day Moving Average | 5.45 |
| 200-Day Moving Average | 5.23 |
| Relative Strength Index (RSI) | 61.50 |
| Average Volume (20 Days) | 88,795 |
Short Selling Information
The latest short interest is 1.31 million, so 4.89% of the outstanding shares have been sold short.
| Short Interest | 1.31M |
| Short Previous Month | 1.26M |
| Short % of Shares Out | 4.89% |
| Short % of Float | 10.39% |
| Short Ratio (days to cover) | 12.31 |
Income Statement
In the last 12 months, SYRS had revenue of $6.98 million and -$144.49 million in losses. Loss per share was -$5.05.
| Revenue | 6.98M |
| Gross Profit | 6.98M |
| Operating Income | -126.70M |
| Pretax Income | -144.49M |
| Net Income | -144.49M |
| EBITDA | -137.32M |
| EBIT | -139.28M |
| Loss Per Share | -$5.05 |
Balance Sheet
The company has $110.42 million in cash and $61.67 million in debt, giving a net cash position of $48.75 million or $1.82 per share.
| Cash & Cash Equivalents | 110.42M |
| Total Debt | 61.67M |
| Net Cash | 48.75M |
| Net Cash Per Share | $1.82 |
| Equity (Book Value) | 15.06M |
| Book Value Per Share | 0.56 |
| Working Capital | 74.90M |
Cash Flow
In the last 12 months, operating cash flow was -$103.90 million and capital expenditures $1.55 million, giving a free cash flow of -$102.35 million.
| Operating Cash Flow | -103.90M |
| Capital Expenditures | 1.55M |
| Free Cash Flow | -102.35M |
| FCF Per Share | -$2.63 |
Margins
Gross margin is 100.00%, with operating and profit margins of -1,814.88% and -2,069.80%.
| Gross Margin | 100.00% |
| Operating Margin | -1,814.88% |
| Pretax Margin | -2,069.80% |
| Profit Margin | -2,069.80% |
| EBITDA Margin | -1,967.02% |
| EBIT Margin | -1,995.07% |
| FCF Margin | -1,466.15% |
Dividends & Yields
SYRS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -40.00% |
| Shareholder Yield | -40.00% |
| Earnings Yield | -86.22% |
| FCF Yield | -61.07% |
Analyst Forecast
The average price target for SYRS is $14.00, which is 123.29% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.00 |
| Price Target Difference | 123.29% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 122.94% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on September 19, 2022. It was a reverse split with a ratio of 1:10.
| Last Split Date | Sep 19, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
SYRS has an Altman Z-Score of -9.4 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.4 |
| Piotroski F-Score | 2 |